Print

Supernus Pharmaceuticals (SUPN) Reports Third Quarter 2012 Financial Results  
11/7/2012 9:13:52 AM

ROCKVILLE, Md., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, reported in the November 2, 2012 filing of the Form 10-Q consolidated financial results for the three and nine months ended September 30, 2012, and provided an update on key accomplishments to date.
//-->